Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis

Tapmeier TT., Rahmioglu N., Lin J., De Leo B., Obendorf M., Raveendran M., Fischer OM., Bafligil C., Guo M., Harris RA., Hess-Stumpp H., Laux-Biehlmann A., Lowy E., Lunter G., Malzahn J., Martin NG., Martinez FO., Manek S., Mesch S., Montgomery GW., Morris AP., Nagel J., Simmons HA., Brocklebank D., Shang C., Treloar S., Wells G., Becker CM., Oppermann U., Zollner TM., Kennedy SH., Kemnitz JW., Rogers J., Zondervan KT.

Genetic analyses in humans and macaques followed by cellular and mouse studies demonstrate NPSR1 as a nonhormonal drug target in endometriosis.

DOI

10.1126/scitranslmed.abd6469

Type

Journal article

Journal

Science Translational Medicine

Publisher

American Association for the Advancement of Science (AAAS)

Publication Date

25/08/2021

Volume

13

Permalink Original publication